Coactivation of Toll-like receptor-3 and -7 in immune complex glomerulonephritis

Prashant S Patole1, Rahul D Pawar, Julia Lichtnekert

  • 1Medical Policlinic, Ludwig-Maximilians-University Munich, Pettenkoferstr. 8a, 80336 Munich, Germany.

Insights

Simultaneous activation of Toll-like receptor (TLR)-3 and TLR7 did not worsen glomerulonephritis in mice. This suggests mechanisms protect against additive TLR3-TLR7 coactivation effects on kidney disease.

Area of Science:

  • Immunology
  • Nephrology
  • Molecular Biology

Background:

  • Viral infections can trigger glomerulonephritis, a kidney inflammation.
  • Toll-like receptors (TLRs) like TLR3 and TLR7 recognize viral RNA and can worsen kidney disease.
  • Previous studies suggested TLR3 and TLR7 coactivation might synergistically impact immune responses.

Purpose of the Study:

  • To investigate if simultaneous TLR3 and TLR7 activation exacerbates glomerulonephritis in MRLlpr mice.
  • To determine if coactivation leads to additive effects on immune markers and kidney pathology.

Main Methods:

  • MRLlpr mice were treated with saline, poly(I:C) (TLR3 agonist), imiquimod (TLR7 agonist), or a combination.
  • Treatments were administered bi-daily from week 16 to 18 of age.
  • Serum levels of cytokines (IL-6, IL12p70), anti-dsDNA antibodies, and glomerulonephritis severity were assessed.

Main Results:

  • Combined TLR3 and TLR7 agonist treatment did not show synergistic effects on serum cytokines, autoantibodies, or glomerulonephritis.
  • In vitro studies showed no synergistic cytokine release from monocytes.
  • Glomerular mesangial cells lacked TLR7 expression, preventing synergistic responses.

Conclusions:

  • Coactivation of TLR3 and TLR7 does not have additive effects on exacerbating glomerulonephritis in MRLlpr mice.
  • Mechanisms exist that protect against detrimental additive effects of TLR3-TLR7 coactivation on renal pathology.

Related Concept Videos

Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...